Le Lézard
Classified in: Health
Subjects: CHI, PDT, DEI

InventHelp Inventors Develop New Fever Pops for Children (AJD-203)


PITTSBURGH, Feb. 14, 2024 /PRNewswire/ -- "I work at a children's hospital and thought there could be a way to administer necessary medications to a young child by taking advantage of their natural affinity for sweet treats," said one of two inventors, from Fairburn, Ga., "so we invented the FEVER POPS. Our flavorful design would help reduce fever and pain while also providing added hydration."

The patent-pending invention provides a new way to administer ibuprofen or acetaminophen to children. In doing so, it enhances convenience, flavor and fun. As a result, it enables the correct dosage to be administered without a fuss. It also offers the added benefit of cooling and hydrating young patients with fevers. The invention features a unique design that is easy to consume so it is ideal for parents with young children, hospitals, etc. Additionally, it is producible in design variations.

The original design was submitted to the Atlanta sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 22-AJD-203, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 07:30
KITS Eyecare Ltd. ("KITS" or the "Company"), the leading vertically integrated eyecare provider, is providing selected preliminary unaudited results for its second quarter ended June 30, 2024....

at 07:15
The National Business League (NBL)®, National Medical Association (NMA)®, and National Bar Association (NBA)® are proud to announce a collaborative effort to address critical issues impacting Black communities. This initiative focuses on protecting...

at 07:05
Natera, Inc. , a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that its latest research and data on prenatal and reproductive genetics will be presented at the 28th International Conference on Prenatal Diagnosis and...

at 06:58
"According to the latest BCC Research study, the demand for "Global Recombinant Proteins Market" is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through...

at 06:30
REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Has Signed a ?37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium ? July 3, 2024, 12:30pm CET / 6:30am ET ? Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)...

at 06:30
Increasing pet ownership and the trend of treating pets as family members, the rising demand for livestock products due to a growing global population, and the need to manage zoonotic diseases to protect public health are some factors driving the...



News published on and distributed by: